Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | TNFRSF8 |
| Gene Name: | TNFRSF8 |
| Protein Full Name: | Tumor necrosis factor receptor superfamily member |
| Alias: | CD30; CD30L receptor; D1S166E; KI-1; Lymphocyte activation antigen CD30; TNR8; Tumor necrosis factor receptor superfamily, member 8 |
| Mass (Da): | 63747 |
| Number AA: | 595 |
| UniProt ID: | P28908 |
| Locus ID: | 943 |
| COSMIC ID: | TNFRSF8 |
| Gene location on chromosome: | 1p36.22 |
| Cancer protein type: | UNCLEAR |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | UNCLEAR |
| Number of cancer specimens: | 19719 |
| Percent of cancer specimens with mutations: | 0.62 |
| Normal role description: | TNFRSF8 is expressed by activated T and B cells and mediate NF-kb signalling for growth and transformation, regulate apoptosis, and protection against autoimmunity. |